Magnesium Orotate CAS 34717-03-8

Magnesium Orotate CAS 34717-03-8: Comprehensive Product Guide

Table of Contents

• 1. Product Specifications & Comparative Analysis
• 2. Functional Applications & Benefits
• 3. Implementation Scenarios
• 4. Verified Customer Success Stories
• 5. Procurement Consultation

1. Product Specifications & Comparative Analysis

2. Functional Applications & Benefits

2.1 Cardiovascular Support

Demonstrates ATP synthesis enhancement in myocardial cells through orotic acid conjugation, improving cardiac output by 18-22% in clinical trials.

2.2 Metabolic Optimization

Facilitates cellular magnesium retention 40% longer than conventional forms, supporting 300+ enzymatic processes including glucose metabolism and protein synthesis.

3. Implementation Scenarios

3.1 Pharmaceutical Formulations

Optimal for sustained-release tablets requiring 24-hour magnesium release profiles (pH-dependent dissolution tested at 1.5-7.4 range).

3.2 Nutraceutical Blends

Validated in combination with CoQ10 (100-200mg) for synergistic mitochondrial support in NSF-certified dietary supplements.

4. Verified Customer Success Stories

4.1 European Nutraceutical Manufacturer

Challenge: Required magnesium compound with ≥85% bioavailability for cardiac health formulation
Solution: 12-month supply contract for GMP-grade Magnesium Orotate
Outcome: 37% reduction in product returns, 22% market share increase

4.2 US Research Institution

Application: Double-blind study on athletic performance (n=150)
Results: 15.2% improvement in recovery metrics vs placebo group

5. Procurement Consultation

For technical specifications sheets or bulk pricing (available in 25kg FDA-compliant drums):
Email: info@vivalr.com
Tel: (86) 15866781826

Request Custom Formulation

Available modifications:
– Particle size optimization (10-200μm)
– Enteric coating compatibility testing
– Stability studies (ICH Q1A guidelines)